Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use REDEMPLO® safely and effectively. See full prescribing information for REDEMPLO. REDEMPLO (plozasiran) injection, for subcutaneous use Initial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-prescription
REDEMPLO is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
- generic_name
- plozasiran
- product_names
- plozasiran
- ndc
- 84141-025, 84141-025-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en